Content about Naltrexone

April 24, 2013
FDA approves drug for opioid-induced constipation

The Food and Drug Administration has approved a new drug for constipation related to use of opioid painkillers made by Sucampo Pharmaceuticals and Takeda Pharmaceuticals, the drug makers said.

February 25, 2013
FDA approves Amneal opioid-dependence drug

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a drug to treat opioid dependence.

February 6, 2013
FDA approves Elite Pharmaceuticals' opioid painkiller

The Food and Drug Administration has approved a regulatory approval application from Elite Pharmaceuticals for an opioid painkiller, the drug maker said Wednesday.

December 22, 2011
Pfizer announces Embeda post-market trial results

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

October 7, 2011
Watson files for approval of generic painkiller

Watson Pharmaceuticals is looking to become the first to market a generic version of a painkiller made by Pfizer, the drug maker said Friday.

September 22, 2011
Orexigen, FDA work out plan for path to approval of obesity drug

Drug maker Orexigen Therapeutics said it had identified a "clear and feasible path" for the approval of its drug for treating obesity by working with the Food and Drug Administration.

August 30, 2011
FDA accepts application for opioid-induced constipation drug

The Food and Drug Administration has accepted a regulatory approval application from Progenics Pharmaceuticals and Salix Pharmaceuticals seeking an additional approval for a pain drug.

February 7, 2011
Salix, Progenics ink licensing deal for Relistor

Salix Pharmaceuticals and Progenics Pharmaceuticals have entered a licensing agreement for a drug used to treat side effects of opioid use.

February 1, 2011
FDA declines to approve Contrave

The Food and Drug Administration has turned down an application for an anti-obesity drug.

October 12, 2010
FDA approves Vivitrol

The Food and Drug Administration approved a drug to treat and prevent relapse after patients...

© 2013 Drug Store News. All Rights Reserved.